ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,655
Screening encounters
4,264
Diagnostic referrals
812
Outstanding pathways
293

Screening pathway

  1. Screening4,264Encounters
  2. Positive finding1,469Documented findings
  3. Referral812Diagnostic referrals
  4. Follow-up953Diagnostic visits
  5. Outcome519Resolved pathways

Stage totals use different units. Pending pathways: 293. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0059 · EXP-0059Synthetic · Site A

Full participant history through 2026-10-13, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · HSIL · Adequate
  3. · Diagnostic referral · EXP-0059-T-R
  4. · Contact attempt · Reached
  5. · Barrier documented · Transport difficulty
  6. · Diagnostic booking · Initial booking
  7. · Navigation intervention · Coordination support
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · High-grade lesion
  11. · Follow-up disposition · Resolved · EXP-0059-T-R
  12. · Treatment · Synthetic precancer treatment
  13. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-05-27
  14. · Surveillance · HPV DNA · Surveillance · After treatment
  15. · Surveillance result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3655 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0163 · Expanded synthetic participant 0163Site C — Rural Outreach Programme
EXP-0164 · Expanded synthetic participant 0164Site C — Rural Outreach Programme
EXP-0165 · Expanded synthetic participant 0165Site D — Community Engagement Programme
EXP-0166 · Expanded synthetic participant 0166Site D — Community Engagement Programme
EXP-0167 · Expanded synthetic participant 0167Site C — Rural Outreach Programme
EXP-0170 · Expanded synthetic participant 0170Site A — Urban Referral Hub
EXP-0171 · Expanded synthetic participant 0171Site C — Rural Outreach Programme
EXP-0172 · Expanded synthetic participant 0172Site C — Rural Outreach Programme
EXP-0173 · Expanded synthetic participant 0173Site B — Peri-Urban Access Programme
EXP-0175 · Expanded synthetic participant 0175Site B — Peri-Urban Access Programme
EXP-0176 · Expanded synthetic participant 0176Site A — Urban Referral Hub
EXP-0179 · Expanded synthetic participant 0179Site D — Community Engagement Programme
EXP-0182 · Expanded synthetic participant 0182Site E — Resource-Constrained Navigation Programme
EXP-0183 · Expanded synthetic participant 0183Site D — Community Engagement Programme
EXP-0184 · Expanded synthetic participant 0184Site E — Resource-Constrained Navigation Programme
EXP-0185 · Expanded synthetic participant 0185Site E — Resource-Constrained Navigation Programme
EXP-0186 · Expanded synthetic participant 0186Site B — Peri-Urban Access Programme
EXP-0187 · Expanded synthetic participant 0187Site A — Urban Referral Hub
EXP-0189 · Expanded synthetic participant 0189Site D — Community Engagement Programme
EXP-0190 · Expanded synthetic participant 0190Site E — Resource-Constrained Navigation Programme
EXP-0191 · Expanded synthetic participant 0191Site E — Resource-Constrained Navigation Programme
EXP-0194 · Expanded synthetic participant 0194Site A — Urban Referral Hub
EXP-0195 · Expanded synthetic participant 0195Site A — Urban Referral Hub
EXP-0196 · Expanded synthetic participant 0196Site E — Resource-Constrained Navigation Programme
EXP-0198 · Expanded synthetic participant 0198Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1659
HPV DNA
2006
Cytology
599

Navigation activity

Barrier documented
716
Contact attempt
1189
Navigation intervention
306
Diagnostic booking
1008
Diagnostic visit
953

Documented barriers

Contact difficulty
230
Transport difficulty
233
Appointment coordination
253

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.